Literature DB >> 14219080

INHIBITION BY METABOLIC ANALOGUES OF PLAQUE FORMATION BY HERPES ZOSTER AND HERPES SIMPLEX VIRUSES.

F RAPP.   

Abstract

Keywords:  HERPES ZOSTER; HERPESVIRUS; HERPESVIRUS HOMINIS; IDOXURIDINE; NUCLEOSIDES; PHARMACOLOGY; THIOSEMICARBAZONES; TISSUE CULTURE; VIRUS CULTIVATION

Mesh：

Substances：

Year:  1964        PMID： 14219080

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  12 in total

1.  Varicella-zoster virus and subcutaneous cytarabine: correlation of in vitro sensitivities to blood levels.

Authors:  D A Zaky; R F Betts; R G Douglas; K Bengali; G L Neil
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  5,6-Dihydro-5-azathymidine: in vitro antiviral properties against human herpesviruses.

Authors:  H E Renis
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

3.  An improved plaque assay for varicella virus.

Authors:  R Hondo; H Shibuta; M Matumoto
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

4.  Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells.

Authors:  T Hackstadt; L P Mallavia
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

Review 5.  The latent herpes simplex virus.

Authors:  J J Docherty; M Chopan
Journal:  Bacteriol Rev       Date:  1974-12

6.  Effect of inhibitors on induction of SV40 tumor antigen by an adenovirus-SV40 hybrid.

Authors:  J L Melnick; F Rapp
Journal:  Arch Gesamte Virusforsch       Date:  1965

7.  Assessment of cytosine arabinoside as an antiviral agent in humans.

Authors:  C B Lauter; E J Bailey; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

8.  Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase.

Authors:  Y C Cheng; T Y Tsou; T Hackstadt; L P Mallavia
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

9.  [Mouse cytomegalovirus infection under cytosine arabinoside treatment].

Authors:  P Peller; O Goetz; M Rath
Journal:  Infection       Date:  1976       Impact factor: 3.553

10.  Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains.

Authors:  M Fiala; A Chow; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.